236 related articles for article (PubMed ID: 25172355)
21. A universal epitope-based influenza vaccine and its efficacy against H5N1.
Adar Y; Singer Y; Levi R; Tzehoval E; Perk S; Banet-Noach C; Nagar S; Arnon R; Ben-Yedidia T
Vaccine; 2009 Mar; 27(15):2099-107. PubMed ID: 19356612
[TBL] [Abstract][Full Text] [Related]
22. Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes.
Pushko P; Pearce MB; Ahmad A; Tretyakova I; Smith G; Belser JA; Tumpey TM
Vaccine; 2011 Aug; 29(35):5911-8. PubMed ID: 21723354
[TBL] [Abstract][Full Text] [Related]
23. Keeping the memory of influenza viruses.
Combadière B; Sibéril S; Duffy D
Pathol Biol (Paris); 2010 Apr; 58(2):e79-86. PubMed ID: 20303671
[TBL] [Abstract][Full Text] [Related]
24. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.
Pariani E; Boschini A; Amendola A; Poletti R; Anselmi G; Begnini M; Ranghiero A; Cecconi G; Zanetti AR
Vaccine; 2011 Nov; 29(49):9209-13. PubMed ID: 21974995
[TBL] [Abstract][Full Text] [Related]
25. A universal flu vaccine.
Kesik-Brodacka M; Plucienniczak G
Acta Biochim Pol; 2014; 61(3):523-30. PubMed ID: 25203218
[TBL] [Abstract][Full Text] [Related]
26. Emulsion-based adjuvants for influenza vaccines.
Vogel FR; Caillet C; Kusters IC; Haensler J
Expert Rev Vaccines; 2009 Apr; 8(4):483-92. PubMed ID: 19348563
[TBL] [Abstract][Full Text] [Related]
27. Influenza viruses and cross-reactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus.
Iorio AM; Bistoni O; Galdiero M; Lepri E; Camilloni B; Russano AM; Neri M; Basileo M; Spinozzi F
Vaccine; 2012 Feb; 30(9):1617-23. PubMed ID: 22245606
[TBL] [Abstract][Full Text] [Related]
28. Pandemic influenza A (H1N1) 2009 vaccine: an update.
Goel MK; Goel M; Khanna P; Mittal K
Indian J Med Microbiol; 2011; 29(1):13-8. PubMed ID: 21304188
[TBL] [Abstract][Full Text] [Related]
29. Development of influenza vaccine production capacity by the Government Pharmaceutical Organization of Thailand: addressing the threat of an influenza pandemic.
Surichan S; Wirachwong P; Supachaturas W; Utid K; Theerasurakarn S; Langsanam P; Lakornrach P; Nitisaporn L; Chansikkakorn C; Vangkanonta W; Kaweepornpoj R; Poopipatpol K; Thirapakpoomanunt S; Srichainak S; Artavatkun W; Chokevivat V; Wibulpolprasert S
Vaccine; 2011 Jul; 29 Suppl 1():A29-33. PubMed ID: 21684425
[TBL] [Abstract][Full Text] [Related]
30. Adapting global influenza management strategies to address emerging viruses.
Noah DL; Noah JW
Am J Physiol Lung Cell Mol Physiol; 2013 Jul; 305(2):L108-17. PubMed ID: 23709619
[TBL] [Abstract][Full Text] [Related]
31. Vaccines to protect humans from pandemic avian influenza strains.
Campbell JD
Md Med; 2006; 7(1):15-8. PubMed ID: 16613361
[TBL] [Abstract][Full Text] [Related]
32. Seasonal influenza vaccination and technologies.
Nafziger AN; Pratt DS
J Clin Pharmacol; 2014 Jul; 54(7):719-31. PubMed ID: 24691877
[TBL] [Abstract][Full Text] [Related]
33. [Pandemic and prepandemic H5N1 influenza vaccines: a 2009 update].
Loulergue P; Launay O
Med Sci (Paris); 2009; 25(8-9):719-25. PubMed ID: 19765386
[TBL] [Abstract][Full Text] [Related]
34. Advances in the development of influenza virus vaccines.
Krammer F; Palese P
Nat Rev Drug Discov; 2015 Mar; 14(3):167-82. PubMed ID: 25722244
[TBL] [Abstract][Full Text] [Related]
35. Adenoviral vectors as novel vaccines for influenza.
Coughlan L; Mullarkey C; Gilbert S
J Pharm Pharmacol; 2015 Mar; 67(3):382-99. PubMed ID: 25560474
[TBL] [Abstract][Full Text] [Related]
36. Towards the knowledge-based design of universal influenza epitope ensemble vaccines.
Sheikh QM; Gatherer D; Reche PA; Flower DR
Bioinformatics; 2016 Nov; 32(21):3233-3239. PubMed ID: 27402904
[TBL] [Abstract][Full Text] [Related]
37. Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines.
Sridhar S
Front Immunol; 2016; 7():195. PubMed ID: 27242800
[TBL] [Abstract][Full Text] [Related]
38. Influenza Vaccine Research funded by the European Commission FP7-Health-2013-Innovation-1 project.
Liu H; Frijlink HW; Huckriede A; van Doorn E; Schmidt E; Leroy O; Rimmelzwaan G; McCullough K; Whelan M; Hak E
Vaccine; 2016 Nov; 34(48):5845-5854. PubMed ID: 27793486
[TBL] [Abstract][Full Text] [Related]
39. Designing multi-epitope mRNA construct as a universal influenza vaccine candidate for future epidemic/pandemic preparedness.
Rcheulishvili N; Mao J; Papukashvili D; Liu C; Wang Z; Zhao J; Xie F; Pan X; Ji Y; He Y; Wang PG
Int J Biol Macromol; 2023 Jan; 226():885-899. PubMed ID: 36521707
[TBL] [Abstract][Full Text] [Related]
40. Recent advances in influenza vaccines.
Pawelec G; McElhaney J
F1000Res; 2020; 9():. PubMed ID: 32399192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
